Basal Cell Skin Cancer Clinical Trials

Find Basal Cell Skin Cancer Clinical Trials Near You

Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice: a Retrospective Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Basal cell carcinoma (BCC) is the most common skin cancer in the Netherlands, with incidence rates continuing to rise. The current diagnostic standard combines clinical evaluation and dermoscopy, while biopsy followed by histopathological examination remains the gold standard when uncertainty about the diagnosis persists. However, biopsy is invasive, time-consuming, and costly. Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive imaging technique that has emerged as a promising alternative to biopsy for BCC suspected lesions. This retrospective study aims to evaluate the real-world clinical performance of LC-OCT in routine dermatological practice, where it has been integrated into the diagnostic work-up for BCC-suspect lesions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients aged ≥18 years

• LC-OCT performed as part of diagnostic evaluation between January 2025 and June 2025 at Mohs clinics in the Netherlands

• Histopathological results (biopsy or excision) and/or 6-12 month clinical follow-up data available

Locations
Other Locations
Netherlands
Maastricht University Medical Center +
RECRUITING
Maastricht
Contact Information
Primary
Yara Valkenburg, MD
yara.valkenburg@mumc.nl
+31(0)43- 387 7295
Backup
Klara Mosterd, MD PhD
+31(0)43- 387 7295
Time Frame
Start Date: 2026-06-15
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 297
Treatments
Patients wit BCC suspected lesions who underwent LC-OCT imaging
Patients with clinically suspected BCC lesions requiring biopsy who underwent LC-OCT imaging as part of routine clinical care at Mohs Clinics.
Related Therapeutic Areas
Sponsors
Leads: Maastricht University Medical Center
Collaborators: Mohs Klinieken

This content was sourced from clinicaltrials.gov